Resother Pharma
Last verified 2026-05-08. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $2.7Mattributed |
|---|---|
| Latest round | grant, $2.7M, 2023-07-01attributed |
| Founded | unknown |
| Headquarters | Copenhagen, Denmark |
| Industry | biotech |
| Stage | unknown |
| Website | resotherpharma.com |
ResoTher Pharma develops peptide-based resolution therapies for diseases driven by inflammation, starting with cardiovascular disease. It is built for patients with conditions like myocardial infarction. Its peptides target neutrophil-driven inflammation through a resolution approach rather than broad anti-inflammatory action.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2023-07-01 | grant | $2.7M | undisclosed |
Detected tech stack
LiteSpeed, WordPress 6.9.4, LiteSpeed Cache, Yoast SEO 27.5, jQuery Migrate 3.4.1, parallax.js, PHP, Python, MySQL, jquery 3.7.1
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $2.7M | attributed | eu-grant named as publisher. No document URL on file. |
| Total raised $2.7M | attributed | eu-grant named as publisher. No document URL on file. |
| Company existence | self-reported | resotherpharma.com, read 2026-05-08 |
| Description | self-reported | resotherpharma.com, read 2026-05-08 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.